Pharmacy · Hodan

Contract C-1310: Medicine stock

Murabaha High riskFully repaid

$1,000$1,000 funded

Expected return

7–9%

Term

4 mo

Backers

Business #K12

Licensed community pharmacy.

The real name is verified by the platform through KYC and kept private. Public IDs are a deliberate security choice.

762 / 1000

762 now

Dotted lines mark the scores needed for T2, T3, T4 and T5.

Contracts fulfilled: 2 / 2

Revenue (latest month)

$6,400

Expenses (latest month)

$5,300

Margin

17%

Reports on time

15/15

Reported by the business and checked against mobile-money statements where provided. Public to everyone.

Tranche 1 · $400Released
Paid directly to the supplier once the contract is signed
Tranche 2 · $400Released
Paid to the supplier after delivery is confirmed
Final payout · $200Released
Controlled by the platform. Released after reports are checked; can be paused if an anomaly is detected

The platform buys the goods from the supplier directly. The business never receives this $1,000 as cash.
The business then repays cost plus a markup agreed at signing, over 4 months. The markup does not grow if repayment is late.
Investors expect 7–9% over the whole term. The range is there because the final supplier invoice sets the exact figure.
If the business fails, you can lose some or all of this money. Recovery goes back to investors in proportion to what each put in.
If fraud is found, the business is permanently banned and what remains is liquidated back to investors.

Risk disclosure

You can lose some or all of your money.

This is a venture market. These are small, young businesses, and some fail. Returns are expectations, not promises.

You may not be able to get your money out before a contract ends. Keep each investment small and spread across businesses.

Contract terms

The platform buys the goods from the supplier directly. The business never receives this $1,000 as cash.

The business then repays cost plus a markup agreed at signing, over 4 months. The markup does not grow if repayment is late.

Investors expect 7–9% over the whole term. The range is there because the final supplier invoice sets the exact figure.

If the business fails, you can lose some or all of this money. Recovery goes back to investors in proportion to what each put in.

If fraud is found, the business is permanently banned and what remains is liquidated back to investors.